IHS Chemical Week

Archives :: Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Displaying 41 - 60 of 429 stories.
May 29, 2009
DSM says that studies done at its R&D labs show that its extreme density (XD) technology boosts bioreactor productivity and titers of mammalian cell culture processes for protein...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-Technology-Raises-Bioreactor-Productivity_19247.html
May 29, 2009
Lonza says it has entered into a manufacturing services agreement with biopharmaceutical firm Morphotek (Exton, PA), to support the development and manufacturing of a subset of...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-Signs-Manufacturing-Agreement-with-U-S-Biopharma-Firm_19248.html
May 29, 2009
Pharmaceutical intermediates and active pharma ingredients (API) manufacturer Minakem (Beuvry-la-Forêt, France) has completed the acquisition of a multi-purpose API plant at...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Minakem-Acquires-API-Plant-from-AstraZeneca_19249.html
May 29, 2009
Roche has signed an agreement to purchase Codex Biocatalyst Panels, a biocatalysis-based research and manufacturing productivity product, from Codexis (Redwood City, CA), a developer...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Roche-Buys-Productivity-Product-from-Codex_19250.html
May 22, 2009
Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-to-Build-Cell-Therapy-Production-Facility-in-Singapore_19099.html
May 22, 2009
Contract manufacturing of active pharmaceutical ingredients (APIs) and finished dosage drug forms will grow in India at 30%-40%/year until 2013, says a new report from Frost &...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/India-to-Remain-a-Cost-Competitive-Hub_19100.html
May 22, 2009
Cambrex (East Rutherford, NJ) reported first-quarter net profits up 12%, to $4.7 million compared with the year-ago period, on sales down by nearly 3%, to $60 million. Sales were...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/First-Quarter-Profits-Rise-at-Cambrex_19101.html
May 11, 2009
Novozymes says it has broken ground on a facility to produce bacillus-based hyaluronic acid (bHA) at its existing Tianjin, China site. The company is also considering establishing a...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Novozymes-Breaks-Ground-in-China-for-Hyaluronic-Acid-Unit_18809.html
May 8, 2009
Sanofi-Aventis (Paris) says it has started up the “Biolaunch project” at its Vitry-sur-Seine (France) pharmaceutical production site. The €200-million ($266 million)...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-to-Establish-Biotech-Facility-in-France_18810.html
May 8, 2009
Pharmaceutical firm Strides Arcolab (Bangalore) says it has begun supplying Oseltamivir capsules, the generic equivalent of Roche’s Tamiflu, to various countries for swine flu...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Strides-Arcolab-to-Up-Production_18811.html
May 8, 2009
Ranbaxy Pharmaceuticals, a Ranbaxy Laboratories (Gurgaon, India) subsidiary, says it has voluntarily recalled its antibiotic nitrofurantoin capsules from the U.S. market, as certain...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Ranbaxy-Recalls-Antibiotic-in-U-S-_18812.html
May 8, 2009
Althea Technologies (San Diego), a biopharmaceutical development and manufacturing services supplier, says it has opened a commercial-scale cGMP facility for biologics and injectables...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Althea-Opens-San-Diego-Facility_18813.html
May 1, 2009
Lonza has completed construction of a 2,000-liter microbial fermentation plant at its Hopkinton, MA site. The company says it has also revamped the site to enhance infrastructure...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-Revamps-U-S-Microbial-Fermentation-Site_18635.html
May 1, 2009
Active pharmaceutical ingredient (API) manufacturer Hovione (Loures, Portugal) says it has opened an API manufacturing site at Cork, Ireland. Pfizer last month completed the hand over...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Hovione-Opens-API-Facility-in-Ireland_18636.html
May 1, 2009
Sanofi-Aventis (Paris) says it will invest €31 million ($41 million) to build a facility at the Hangzhou Binjiang New Development Zone (Hangzhou, China), which will take on...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-to-Build-Pharma-Plant-in-China_18637.html
April 24, 2009
GlaxoSmithKline (GSK) says it has signed an agreement to acquire dermatological product firm Stiefel Laboratories (Coral Gables, FL), for about $3.6 billion. The deal calls for GSK and...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/GSK-Inks-Deal-to-Buy-Stiefel-for-$3-6-billion_18479.html
April 24, 2009
DSM says that its DSM Pharmaceutical Products custom manufacturing business unit has entered into a multimillion-dollar contract to make and supply pharmaceuticals for Shire US...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-to-Supply-Shire-US-Manufacturing_18480.html
April 24, 2009
Sanofi-Aventis (Paris) says it has agreed to acquire Medley (Campinas, Brazil), Brazil’s largest generics drugmaker and third-largest pharmaceutical company, for about €500...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-to-Buy-Firms-in-Brazil-and-U-S-_18498.html
April 24, 2009
Reaxa (Manchester, U.K.), a catalyst technology provider for pharmaceutical and fine chemical manufacturers, says it expects India to become one of its major markets in the next 12...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Indian-Market-to-Boost-Reaxas-Growth_18499.html
April 10, 2009
Dishman Pharmaceuticals & Chemicals (Ahmedabad, India) says it has signed a cooperation and joint active pharmaceutical ingredient (API) development agreement with Polpharma...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Dishman-Signs-API-Development-Deal-with-Polish-Firm_18201.html
Pages: « Previous  1 2 [3] 4 5 6 7 8 9 10 11 12 Next »










 
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa